[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Resident's Forum
June 2013

Effect of Insurance Payer Status on the Surgical Treatment of Early Stage Breast CancerData Analysis From a Single Health System

Author Affiliations
 

SECTION EDITORS: RICHARD D. SCHULICK, MD, MBA; PAMELA A. LIPSETT, MD, MPHE

Author Affiliations: Department of Surgery, University of Toledo Medical Center (Drs Adepoju, Qu, and Williams); Sponsored Research (Mr Wanjiku, Ms Brown, and Dr Redfern), and Department of Surgery (Dr Sferra), Promedica Health System, Toledo, Ohio.

JAMA Surg. 2013;148(6):570-572. doi:10.1001/jamasurg.2013.61
Abstract

The effect of insurance payer status on surgical treatment of early stage breast cancer is unclear. This retrospective study examined the effect of insurance payer on mastectomy rates of 1539 women treated within a single health system. Women with Medicaid had significantly larger tumors compared with those with private insurance (PI) at diagnosis (3.3 cm vs 2.1 cm, P < .05) and were more likely to be treated with mastectomy for larger tumors compared with women with PI. However, women with PI were more likely to have mastectomy for smaller tumors; among women with tumors less than 2 cm, 11% with Medicaid underwent mastectomy compared with 47% with PI (P < .05). Overall, when compared with those with PI, women with Medicaid were more likely to receive mastectomy (60% vs 39%, P < .05).

×